12
Participants
Start Date
January 28, 2019
Primary Completion Date
March 3, 2019
Study Completion Date
BI 1323495,
single oral doses
Humanpharmakologisches Zentrum Biberach, Biberach
Lead Sponsor
Boehringer Ingelheim
INDUSTRY